Vertex Pharma could be close to succeeding in the long-standing quest to find an alternative to potentially addictive opioids for the treatment of pain associated with common medical procedures.

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

The original electronics tool kit: Designed for computer, smartphone, tablet, and gaming repair, backed by thousands of free instructions. Intentional selection: All the tools you need ...

Since Magneto is a Vanguard, his main role is related to him being on the front lines of his team. With a wide range of abilities that range from a protective barrier to block incoming attacks to ...

The Repair Shop viewers were blown away by the restoration of a historic rugby shirt ...